藥 物 回 收
|
| |
| Singapore: Recall of Xofluza Film Coated Tablets 40 mg (English only) |
| |
Health Sciences Authority (HSA) announces that Roche Singapore Pte. Ltd. is recalling one batch of Xofluza Film Coated Tablets 40 mg (baloxavir marboxil) (batch number: B8160N03) to the wholesale level. The affected batch was printed with an incorrect expiry date. As a precautionary measure, the affected batch is recalled.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-xofluza-film-coated-tablets-40-mg
In Hong Kong, Xofluza Tablets 40mg (HK-66117) is a pharmaceutical product registered by Roche Hong Kong Limited (Roche). The product is a prescription-only medicine. As confirmed with Roche, the affected batch has not been distributed into the local market.
Ends/Tuesday, Jun 21, 2022
Issued at HKT 16:00
|
| |
